LivaNova - Healthcare Professionals

We continue to advance medical device solutions for people affected by drug-resistant epilepsy, difficult-to-treat depression, heart failure and obstructive sleep apnea. We collaborate with top researchers, partners and experienced clinicians to enhance solutions, improve patient outcomes and achieve physician satisfaction by providing safe and effective treatment options that positively impact quality of life.

By continuing in this section, you acknowledge that you are a healthcare professional.

Drug-Resistant Epilepsy

VNS Therapy® is your first-choice add-on for restoring wellbeing in people with DRE, because it delivers superior patient outcomes, provides value and is easy to use.1
 

Discover More

Difficult-to-Treat Depression

We offer a unique, non-drug treatment for depression when other antidepressant treatments have failed to achieve remission or maintain durability of treatment effect. VNS Therapy® carries CE Mark and has FDA approval. It has been shown to provide significant and lasting improvements for patients.
 

Discover More

Heart Failure

A new form of therapy is being evaluated for patients with heart failure. It is called Autonomic Regulation Therapy (ART) delivered through Vagus Nerve Stimulation (VNS). ART is investigational and being studied in a clinical trial called ANTHEM-HFrEF.
 

Contact Us

Obstructive Sleep Apnea

LivaNova has CE Mark for an innovative, fully implantable device that treats obstructive sleep apnea (OSA) through hypoglossal nerve stimulation. Mild stimulation to the tongue muscles opens the airway while a patient is sleeping.
 

Discover More